blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1874783

EP1874783 - SUBSTITUTED OXA-DIAZA-SPIRO-[5.5]-UNDECANONE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.04.2011
Database last updated on 25.09.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[2008/02]
Inventor(s)01 / JANSSENS, Frans Eduard
Janssen Pharmaceutica N.V., Turnhoutseweg 30
2340 Beerse / BE
02 / COUPA, Sophie, Johnson & Johnson Pharmaceutical
Res.& Dev. A div. Janssen-Cilag Campus Maigremont
BP 615, F-27106 Val-de-Reuil Cedex / FR
03 / PONCELET, A.Ph., Johnson & Johnson Pharmaceutical
Res.& Dev. A div. Janssen-Cilag Campus Maigremont
BP 615, F-27106 Val-de-Reuil Cédex / FR
04 / SCHOENTJES, Bruno Johnson & Johnson Pharmaceutical
Res.& Dev. A div. Janssen-Cilag Campus Maigremont
BP 615, F-27106 Val-de- Reuil Cédex / FR
 [2008/02]
Representative(s)Quaghebeur, Luc
Johnson & Johnson
Patent Law Department
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2008/02]Quaghebeur, Luc
Janssen Pharmaceutica N.V., Patent Department, Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date06708618.103.03.2006
[2008/02]
WO2006EP60419
Priority number, dateEP2005010165703.03.2005         Original published format: EP 05101657
[2008/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006094934
Date:14.09.2006
Language:EN
[2006/37]
Type: A1 Application with search report 
No.:EP1874783
Date:09.01.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 14.09.2006 takes the place of the publication of the European patent application.
[2008/02]
Type: B1 Patent specification 
No.:EP1874783
Date:26.05.2010
Language:EN
[2010/21]
Search report(s)International search report - published on:EP14.09.2006
ClassificationIPC:C07D498/10, A61K31/537, A61P25/18, A61P25/24
[2008/02]
CPC:
C07D498/10 (EP,KR,US); A61K31/537 (KR); A61P1/00 (EP);
A61P1/08 (EP); A61P1/18 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P15/00 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/18 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P43/00 (EP); B82Y5/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/02]
Extension statesAL04.10.2007
BA04.10.2007
HR04.10.2007
MK04.10.2007
YU04.10.2007
TitleGerman:SUBSTITUIERTE OXADIAZASPIRO-[5.5]-UNDECANONDERIVATE UND IHRE VERWENDUNG ALS NEUROKININANTAGONISTEN[2008/02]
English:SUBSTITUTED OXA-DIAZA-SPIRO-[5.5]-UNDECANONE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS[2008/02]
French:DÉRIVÉS D'OXA-DIAZA-SPIRO[5.5]-UNDÉCANONE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DE LA NEUROKININE[2008/02]
Entry into regional phase04.10.2007National basic fee paid 
04.10.2007Designation fee(s) paid 
04.10.2007Examination fee paid 
Examination procedure04.10.2007Examination requested  [2008/02]
20.05.2008Despatch of a communication from the examining division (Time limit: M04)
13.08.2008Reply to a communication from the examining division
05.11.2009Communication of intention to grant the patent
10.02.2010Fee for grant paid
10.02.2010Fee for publishing/printing paid
Opposition(s)01.03.2011No opposition filed within time limit [2011/18]
Fees paidRenewal fee
31.03.2008Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
31.03.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
HU26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
TR26.05.2010
BG26.08.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
[2013/45]
Former [2013/44]AT26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
TR26.05.2010
BG26.08.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2013/42]AT26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
BG26.08.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/17]AT26.05.2010
CY26.05.2010
CZ26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
RO26.05.2010
SE26.05.2010
SI26.05.2010
SK26.05.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/09]AT26.05.2010
CY26.05.2010
DK26.05.2010
EE26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
NL26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
PT27.09.2010
Former [2011/05]AT26.05.2010
CY26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Former [2011/04]AT26.05.2010
FI26.05.2010
LT26.05.2010
LV26.05.2010
PL26.05.2010
SE26.05.2010
SI26.05.2010
GR27.08.2010
IS26.09.2010
Cited inInternational search[YD]WO9724324  (JANSSEN PHARMACEUTICA NV [BE], et al) [YD] 1-19* page 32; table 2 *;
 [AD]WO0194346  (HOFFMANN LA ROCHE [CH]) [AD] 1-19 * page 1 - page 2 *;
 [Y]WO02092604  (HOFFMANN LA ROCHE [CH]) [Y] 1-19 * example -; claim - *;
 [A]EP1308439  (WELFIDE CORP [JP]) [A] 1-19 * page 133; example 129 *;
 [A]WO03057698  (ACADIA PHARM INC [US]) [A] 1-19 * example - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.